Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB2891 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB2891, RRID:AB_1575705
- Product name
- MAPK7 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of MAPK7.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references Components of a new human protein kinase signal transduction pathway.
Primary structure of BMK1: a new mammalian map kinase.
Zhou G, Bao ZQ, Dixon JE
The Journal of biological chemistry 1995 May 26;270(21):12665-9
The Journal of biological chemistry 1995 May 26;270(21):12665-9
Primary structure of BMK1: a new mammalian map kinase.
Lee JD, Ulevitch RJ, Han J
Biochemical and biophysical research communications 1995 Aug 15;213(2):715-24
Biochemical and biophysical research communications 1995 Aug 15;213(2):715-24
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of MAPK7 polyclonal antibody (Cat # PAB2891) in HL-60 cell lysate. MAPK7 (arrow) was detected using purified polyclonal antibody. Secondary HRP-anti-rabbit was used for signal visualization with chemiluminescence.
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Formalin-fixed and paraffin-embedded human cancer tissue reacted with MAPK7 polyclonal antibody (Cat # PAB2891) , which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma.
- Validation comment
- Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)